Basket | Login

 
 
 
 

Ongoing studies but not recruiting participants

Phase II trials

This section of Clinical Trials Watch contains information about some clinical trials that are:

  • Ongoing but not recruiting participants
  • Conducted at least in one European country
  • In phase II

In these ongoing studies listened below, participants are receiving an intervention or being examined but new potential participants are not currently being recruited.

Study

Study sponsor

Name of the drug

Condition

Estimated end of the study

ABvac40

Araclon Biotech S.L.

ABvac40

Mild cognitive impairment or very mild Alzheimer's disease

February 2022

LAURIET

Genentech

RO7105705

Moderate Alzheimer's disease

June 2023

MAPT-CS1

Ionis Pharmaceuticals

IONIS MAPTRx

Mild Alzheimer's disease

May 2022

RO7105705

Genentech / Roche

RO7105705

Prodromal to Mild Alzheimer's Disease

September 2022

TANGO

Biogen

BIIB092

Early Alzheimer's disease

June 2024

 

This list is a not exhaustive resource of information and could be downloaded as a pdf file below.

Please note that an accessible easy read version of these studies is available as a pdf below. This pdf file includes more information on the studies as well as the link to the full text.

 

 
 

Last Updated: Monday 18 January 2021

 

 
  • Acknowledgements

    Alzheimer Europe's Clinical Trial Watch received funding under an operating grant from the European Union’s Health Programme (2014–2020).
  • European Union
 
 

Options